261 related articles for article (PubMed ID: 18780571)
21. Acute promyelocytic leukemia: what is the new standard of care?
Watts JM; Tallman MS
Blood Rev; 2014 Sep; 28(5):205-12. PubMed ID: 25107311
[TBL] [Abstract][Full Text] [Related]
22. Clinical roundtable monograph. Early death in patients with acute promyelocytic leukemia.
Tallman M; Lo-Coco F; Kwaan H; Sanz M; Gore S
Clin Adv Hematol Oncol; 2011 Feb; 9(2):1-16. PubMed ID: 22379665
[TBL] [Abstract][Full Text] [Related]
23. Genital ulcers after treatment with all-trans-retinoic acid in a child with acute promyelocytic leukemia.
Unal S; Gümrük F; Cetin M; Hiçsönmez G
Pediatr Hematol Oncol; 2005; 22(5):357-9. PubMed ID: 16020125
[TBL] [Abstract][Full Text] [Related]
24. Arsenic in the cerebrospinal fluid of a patient receiving arsenic trioxide for relapsed acute promyelocytic leukemia with CNS involvement.
Knipp S; Gattermann N; Schapira M; Käferstein H; Germing U
Leuk Res; 2007 Nov; 31(11):1585-7. PubMed ID: 17416415
[TBL] [Abstract][Full Text] [Related]
25. Treatment of acute promyelocytic leukemia during pregnancy.
Yang D; Hladnik L
Pharmacotherapy; 2009 Jun; 29(6):709-24. PubMed ID: 19476422
[TBL] [Abstract][Full Text] [Related]
26. The association of ICAM-1 Exon 6 (E469K) but not of ICAM-1 Exon 4 (G241R) and PECAM-1 Exon 3 (L125V) polymorphisms with the development of differentiation syndrome in acute promyelocytic leukemia.
Dore AI; Santana-Lemos BA; Coser VM; Santos FL; Dalmazzo LF; Lima AS; Jacomo RH; Elias J; Falcão RP; Pereira WV; Rego EM
J Leukoc Biol; 2007 Nov; 82(5):1340-3. PubMed ID: 17704297
[TBL] [Abstract][Full Text] [Related]
27. Arsenite medicinal use, metabolism, pharmacokinetics and monitoring in human hair.
Nicolis I; Curis E; Deschamps P; Bénazeth S
Biochimie; 2009 Oct; 91(10):1260-7. PubMed ID: 19527769
[TBL] [Abstract][Full Text] [Related]
28. Practice points, consensus, and controversial issues in the management of patients with newly diagnosed acute promyelocytic leukemia.
Sanz MA; Tallman MS; Lo-Coco F
Oncologist; 2005; 10(10):806-14. PubMed ID: 16314291
[TBL] [Abstract][Full Text] [Related]
29. Overexpression of BP1, a homeobox gene, is associated with resistance to all-trans retinoic acid in acute promyelocytic leukemia cells.
Awwad RT; Do K; Stevenson H; Fu SW; Lo-Coco F; Costello M; Campbell CL; Berg PE
Ann Hematol; 2008 Mar; 87(3):195-203. PubMed ID: 18026954
[TBL] [Abstract][Full Text] [Related]
30. Comparison of anthracycline-based combination chemotherapy with or without all-trans retinoic acid in acute promyelocytic leukemia.
Raza S; Ullah K; Ahmed P; Khan B
J Coll Physicians Surg Pak; 2008 Sep; 18(9):546-50. PubMed ID: 18803891
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of class I phosphoinositide 3-kinase activity impairs proliferation and triggers apoptosis in acute promyelocytic leukemia without affecting atra-induced differentiation.
Billottet C; Banerjee L; Vanhaesebroeck B; Khwaja A
Cancer Res; 2009 Feb; 69(3):1027-36. PubMed ID: 19176369
[TBL] [Abstract][Full Text] [Related]
32. [Molecule targeted therapy for hematological malignancies].
Naoe T
Gan To Kagaku Ryoho; 2001 Feb; 28(2):131-4. PubMed ID: 11242632
[TBL] [Abstract][Full Text] [Related]
33. Open issues on bleeding and thrombosis in acute promyelocytic leukemia.
Sanz MA; Montesinos P
Thromb Res; 2010 Apr; 125 Suppl 2():S51-4. PubMed ID: 20434005
[TBL] [Abstract][Full Text] [Related]
34. Acute intestinal pseudo-obstruction after induction treatment of relapsed acute promyelocytic leukemia with arsenic trioxide.
Park JA; Yun JH; Kang HJ; Shin HY; Ahn HS
Pediatr Blood Cancer; 2008 Apr; 50(4):872-4. PubMed ID: 17635008
[TBL] [Abstract][Full Text] [Related]
35. Precursor T-lymphoblastic lymphoma as a secondary malignancy in a young patient after successful treatment of acute promyelocytic leukemia.
Szotkowski T; Jarosova M; Faber E; Hubacek J; Hlusi A; Papajik T; Pikalova Z; Kucerova L; Holzerova M; Budikova M; Buriankova E; Plachy R; Potomkova J; Klusova N; Szotkowska R; Indrak K
Onkologie; 2009 Sep; 32(8-9):513-5. PubMed ID: 19745598
[TBL] [Abstract][Full Text] [Related]
36. [Urgent states in hematology: acute promyelocytic leukemia--principles of diagnosis].
Schwarz J; Kacírková P; Marková J; Mikulenková D; Marinov I; Ballingová I; Michalová K
Vnitr Lek; 2008; 54(7-8):728-44. PubMed ID: 18780572
[TBL] [Abstract][Full Text] [Related]
37. Increased oxidative DNA products in patients with acute promyelocytic leukemia during arsenic therapy.
Ninomiya M; Kajiguchi T; Yamamoto K; Kinoshita T; Emi N; Naoe T
Haematologica; 2006 Nov; 91(11):1571-2. PubMed ID: 17082016
[TBL] [Abstract][Full Text] [Related]
38. Relationship between cytokines and leukocytosis in patients with APL induced by all-trans retinoic acid or arsenic trioxide.
Bi KH; Jiang GS
Cell Mol Immunol; 2006 Dec; 3(6):421-7. PubMed ID: 17257495
[TBL] [Abstract][Full Text] [Related]
39. [From chloroma to acute promyelocytic leukemia--a historical perspective].
Schwarz J
Vnitr Lek; 2008; 54(7-8):686-700. PubMed ID: 18780570
[TBL] [Abstract][Full Text] [Related]
40. The Combination of Gefitinib With ATRA and ATO Induces Myeloid Differentiation in Acute Promyelocytic Leukemia Resistant Cells.
de Almeida LY; Pereira-Martins DA; Weinhäuser I; Ortiz C; Cândido LA; Lange AP; De Abreu NF; Mendonza SES; de Deus Wagatsuma VM; Do Nascimento MC; Paiva HH; Alves-Paiva RM; Bonaldo CCOM; Nascimento DC; Alves-Filho JC; Scheucher PS; Lima ASG; Schuringa JJ; Ammantuna E; Ottone T; Noguera NI; Araujo CL; Rego EM
Front Oncol; 2021; 11():686445. PubMed ID: 34650910
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
